Hyaluronic acid fillers 


We are a distributor of ELOQUENCE hyaluronic acid with lidocaine – produced by the Korean company Jetema, one of the largest manufacturers of hyaluronic acid in the world (including Regenovue, e.p.t.q.). The brand's products meet the highest standards of HA filler production – they are gel preparations with a high HA content (24 mg/ml) and an addition of lidocaine, characterized by high viscoelasticity, very low endotoxin content (less than 0.1EU), and ease of administration due to optimized injection pressure in the syringe.

The ELOQUENCE range consists of 3 fillers:


Applications: superficial wrinkles, lines around the eyes, crow's feet, frown lines, neck folds, and the areas around the mouth.


Applications: deep wrinkles, nasolabial folds, volumetry, contouring and filling defects in the areas of the cheeks, chin, forehead, lips, and nose.


Applications: deep wrinkles, nasolabial folds, lip enhancement, cheeks, forehead, and nasal dorsum augmentation.

 Production technology

ELOQUENCE products are manufactured according to 9 criteria that adhere to the highest standards of HA filler production (The IX Essential Process):
  1. Safety of raw materials used in filler production – in an exclusive, controlled production line.
  2. High purity HA with high content – ensures durability of effects and prevents swelling.
  3. High viscoelasticity for visible tissue lifting.
  4. Technology for homogeneous implementation of molecules (uniformly sized molecules) – ensures consistency for easier modeling during procedures.
  5. Absence of chemical catalyst residues throughout the cross-linking process.
  6. Aseptic production environment to prevent side effects.
  7. Less than 0.1 EU/ml endotoxin levels.
  8. Minimization of pain, with pH and osmotic pressure similar to that of the human body.
  9. Optimized injection pressure ensures even distribution of filler and prevents focal accumulation.
The ZEEP (Zero Endotoxin & BDDE Entire Process) technology used by Eloquence maintains endotoxin levels below 0.1 EU/ml. The absence of detectable BDDE residues minimizes the risk of side effects that may occur post-procedure.
The Downing Process is Jetema's proprietary method for producing hyaluronic acid molecules of uniform size. Optimized injection pressure prevents uneven and focal accumulation of the acid in tissues.
Minimizing the input amounts of BDDE – MoD (Degree of Modification) is an indicator that determines the total amount of BDDE used as a modifying agent during the production process of hyaluronic acid compared to the total amount of HA. The MoD of Eloquence is 1/6 lower compared to other fillers, making it safer.
Maximizing cross-linking efficiency – through an enhanced physical cross-linking process aimed at achieving complete cross-linking while minimizing the use of BDDE as a chemical catalyst, Eloquence has achieved a gel with high viscoelastic properties.
High viscoelasticity and coherence – Eloquence fillers exhibit viscoelasticity and coherence comparable to other products on the market that contain higher amounts of BDDE.